* St ' 18TH JUDICIAL DISTRICT COURT PARISH OF IBERVILLE STATE OF LOUISIANA PLAINTIFF'S EXHIBIT EXX RR JOSEPH A.

(( 1 EUGENE BROWN, JR.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF Financial condition and results of operations Eaton Corporation OVERVIEW The Company experienced an extraordinary year of achievement in 1993.

I Expense for postretirement benefits other than pensions for the years ended December 31 follows (in millions): 1996 1995 1994 Service cost --benefits earned during year Interest cost on projected benefit obligation Amortization The liability for postretirement benefit plans other than pensions at December 31 follows (in millions): 1996 1995 Accumulated postretirement benefit obligation Retirees Eligible plan participants Non-eligible plan participants Unamortized Prior service cost Net loss Actuarial assumptions used in the calculation of the liability for postretirement benefits other than pensions are as follows: 1996 1995 1994 Discount rate Projected health care cost trend rate ""--rimate trend rate ar ultimate trend rate is achieved An increase of 1% in assumed health care cost trend rates would in crease the accumulated postretirement benefit obligation as of Decem ber 31,1996 by $35 million and the net periodic cost for 1996 by $3 million.

*|rll n, 193* TOl- tfr-^1 yrt^ II-- tafHIa I.

PURCHASE OftOCR ,^ IP jVNY fXTHA COPr BftB 1ft) ACCOUNT CODE TERMS it-M DATE m?

AFFIDAVIT OF DAVID S.

DATE: March 11, 1992 TO: FROM: ALL EMPLOYEES (j^D.

A Division of Die Society of The Plastics Industry, Inc.

1803 BUILDING May 28,1991 The Dow Chemical Company 'Jialano V cHiaan 48674 Mr.

A Division of The Society of The Plastics Industry, Inc.

NEWSUNITED STATES/AMERICAS PVC, chlorine makers urged to prepare for 'sea changes' The latest prediction for a bleak fu ture for chlorine comes from a consult ing service that prepared an economic report for the Chlorine Institute (Wash ington) earlier this year.

Applied Epidemiology, Inc. baseline study results and Wong et al., 1992 results: Observed (Obs) and expected (Exp) deaths, standardized mortality ratios (SMR's) and ninety-five percent confidence intervals (95% CFs) using U.S. white male mortality rates, plant state-specific white male mortality rates, for follow-up through December 31, 1982 Cause of death All causes Obs 1569 Applied Epidemiology, Inc. baseline analysis U.S. reference rates State reference rates Exp SMR 95% Cl Exp SMR 95% Cl 1734.92 90 86-95 1876.87 84 80-88 Obs 1536 Wong et al., 1992 U.S. reference rates Exp 1705.27 SMR 90 95% Cl 86-95 All malignant neoplasms Cancer of: Buccal cavity & pharynx Tongue Other parts buccal cavity Pharynx Digestive organs & peritoneum Esophagus Stomach Intestine, except rectum Rectum Liver & biliary tract Pancreas 389 363.09 107 97-118 380.46 102 92-113 359 341.73 105 94-17 13 11.81 110 59-188 11.61 112 60-192 12 4 2.74 146 40-374 2.56 156 43-400 4 3 3.15 95 20-278 2.98 101 21-294 3 5 5.66 88 29-206 5.79 86 28-202 4 106 94.82 112 92-135 91.43 116 95-140 99 7 8.59 81 33-168 8.37 84 34-172 7 11 16.10 68 34-122 14.78 74 37-133 10 21 31.44 67 41-102 29.57 71 44-109 20 5 9.71 51 17-120 8.89 56 18-131 5 39 8.11 481 342-657 9.11 428 304-585 37 18 19.21 94 55-148 18.89 95 56-151 16 11.55 nr nr nr 89.21 8.07 16.01 28.79 9.91 5.77 18.40 104 54-181 Ill 90-135 87 35-179 63 30-115 70 42-107 50 16-118 641 450-884 87 50-141 C M A 171082 Page i of6 Applied Epidemiology, Inc. baseline analysis Wong et al., 1992 U.S. reference rates State reference rates U.S. reference rates Cause of death Obs Exp SMR 95% Cl Exp SMR 95% Cl Obs Exp SMR 95% Cl Peritoneum & other digestive organs 5 1.65 302 98-706 1.82 274 89-640 4 nr - Respiratory system 128 132.71 96 80-115 151.35 85 71-101 115 122.25 94 78-113 Larynx 3 5.44 55 11-161 5.94 50 10-148 3 5.24 57 12-168 Trachea, bronchus & lung 122 125.56 97 81-116 143.58 85 71-101 111 115.87 96 79-116 Other respiratory system 3 1.71 176 36-513 1.83 164 34-480 1 nr -- Prostate Kidney 15 16.55 91 51-149 15.59 96 54-159 `5 15.20 99 55-163 11 9.53 115 58-207 9.73 113 56-202 1!

in (3 (3 \sr (3 Q (VI ir3Un-Dc00- 00 (oM cm in Ed vmvoo N rinH a: (JV oonv ID tH <i3 f\l aI. i0n) t R&S 144701 Evaluation Matrix For VCM Industry-Wide Cohort Study Update Proposals Proposal Criterion Applied Health Sciences Applied Epidemiology Verify dataset completeness Obtain death certificates from previous update Follow-up vital status ascertainment to 1992 Obtain death certificates through 1992 Mortality analysis completeness Update employment history to 1992 Apply regression modeling Update coding of cause of death New York University I6a/>) ioQ\n m * Uii>ns]r cecoo- CcsM CM -M- ' m2 6) j|j 7 Si au.i * in , ' t R&S 144702 Evaluation Matrix For VCM Industry-Wide Cohort Study Update Proposals Proposal Criterion Applied Health Sciences Applied Epidemiology Use state and local mortality rates Include race-specific analysis Prepare written protocol Time frame for study Total study cost Other Overall New York University in e 63 <r ia--

CHEMICAL MANUFACTURERS ASSOCIATION August 17,1995 Dear Vinyl Chloride Health Committee Members: The following items are enclosed for your review and action: 1. a meeting availability calendar.